The ITA reports: Madeleine Egle accepts 20-month ban for three violations of reporting requirements

Lausanne (ITA/22 Sept 2025) The International Testing Agency (ITA), which conducts an independent anti-doping program on behalf of the International Luge Federation (FIL), reports that Austrian luger Madeleine Egle has accepted a 20-month ban for an anti-doping rule violation (ADRV).

The ITA reports that luger Madeleine Egle has agreed to the consequences for her ADRV in accordance with Article 2.4 of the FIL Anti-Doping Rules (FIL ADR).

Madeleine Egle committed three whereabouts failures within a 12-month period. The athlete did not contest the ADRV and agreed to the consequences proposed by the ITA. Accordingly, the case was settled by the acceptance of the consequences.

The athlete's suspension is effective from March 1, 2025, to October 31, 2026. In addition, all of the athlete's individual competition results from March 1, 2025, will be disqualified, including the loss of medals, points, and prize money.

The decision may be appealed by the parties who are eligible to appeal under Article 13.2.3 of the FIL ADR before the Appeals Chamber of the Court of Arbitration for Sport.

The ITA will not comment further on this case.

[1] Athletes have the right to opt out of having their case referred to a hearing panel. In such cases, the anti-doping organization will evaluate the athlete's file and determine the applicable consequences in accordance with the anti-doping rules, and the athlete has the right to accept the proposed consequences. If the athlete rejects the proposed consequences, the case is referred to a hearing panel. This resolution mechanism is provided for in Article 8.3.1 of the FIL Anti-Doping Rules and Article 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is considered a decision of the FIL/ITA.

[2] Athletes who are included in a Registered Testing Pool (RTP), such as Madeleine Egle, are required to provide their whereabouts on a daily basis, as well as a specific 60-minute time window during which they are available for testing. This is to enable anti-doping organizations to locate athletes for unannounced testing outside of competitions. Any combination of three missed tests (relating to the athlete's unavailability in relation to their 60-minute time slot) and/or reporting failures (caused by the athlete not accurately reporting their whereabouts) committed within a 12-month period shall be considered an ADRV under Article 2.4 of the FIL ADR and the World Anti-Doping Code.